**Executive Summary**
On April 15, 2026, the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, signed a grant agreement with Novartis Healthcare Private Limited (NHPL) to implement the "Development Pioneer Grant." This collaboration aims to foster industry-academia synergy by supporting cutting-edge faculty research and aligning academic innovation with pharmaceutical industry requirements. One faculty member from NIPER Mohali was selected as the grant recipient following a competitive evaluation of 42 proposals from across all seven NIPERs.
**Key Points / Main Content**
**Agreement and Collaboration**
* NIPER Mohali and NHPL formalized a partnership to support the Development Pioneer Grant for NIPERs.
* The agreement was signed in New Delhi in the presence of the Secretary of the Department of Pharmaceuticals.
* The initiative is designed to strengthen the linkage between academic research and industry-driven innovation.
**Grant Selection Process**
* The grant provided a competitive platform for faculty members from all seven NIPER institutions to submit R&D proposals.
* An independent jury evaluated 42 submitted proposals through a rigorous and structured process.
* A faculty member from NIPER Mohali was selected as the final recipient of the prestigious grant.
**Strategic Objectives**
* Enhancing academic research capabilities and driving pioneering advancements in Indian healthcare.
* Moving research efforts beyond pilot stages to ensure they are effectively aligned with commercial industry needs.
* Integrating NIPER more deeply into the broader pharmaceutical innovation ecosystem and reinforcing scientific excellence.
**Impact Analysis**
**Stakeholder: NIPER Mohali Faculty**
**Impact**
The grant provides a prestigious platform and resources for faculty to conduct high-level R&D and transition research from pilot stages to impactful industry-aligned solutions.
**Action Required**
The selected faculty recipient must carry out the proposed research and ensure outcomes meet the innovation-driven standards established by the grant.
**Stakeholder: Novartis Healthcare Private Limited (NHPL)**
**Impact**
NHPL strengthens its role in the pharmaceutical ecosystem by backing academic initiatives that drive healthcare advancements and industry-relevant innovation.
**Action Required**
Support the research initiative through the Development Pioneer Grant and collaborate with the academic institution to guide research toward industry requirements.
**Stakeholder: Department of Pharmaceuticals (Ministry of Chemicals and Fertilizers)**
**Impact**
The department achieves progress in its vision to nurture strong industry-academia linkages and enhance the national healthcare innovation landscape.
**Action Required**
Continue to oversee and expand such initiatives to ensure academic research across all NIPERs remains relevant to the evolving needs of the pharmaceutical sector.
Key Entities Referenced
National Institute of Pharmaceutical Education and Research (NIPER), Mohali: The academic institution and primary grant recipient that entered into an agreement to strengthen pharmaceutical research and innovation.
Novartis Healthcare Private Limited (NHPL): The private healthcare company providing the Development Pioneer Grant to support faculty research and industry-academia synergy.
Development Pioneer Grant for NIPERs: A competitive grant initiative supported by NHPL to promote cutting-edge research and innovation-driven partnerships within NIPER institutions.
Department of Pharmaceuticals: The government department overseeing the collaboration to ensure research efforts align with industry requirements and enhance India's pharmaceutical innovation ecosystem.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
NIPER Mohali signs grant agreement with
Novartis Healthcare Private Limited (NHPL) to
Support Faculty Research Through Development
Pioneer Grant
Industry-Academia Synergy Strengthened as Novartis Backs
NIPER Research Initiative
New Grant Collaboration Boosts Innovation and R&D
Capabilities at NIPER Mohali
Posted On: 15 APR 2026 3:20PM by PIB DelhiIn a significant step towards fostering academia-industry collaboration and strengthening research and
innovation in the pharmaceutical sector, the National Institute of Pharmaceutical Education and
Research (NIPER), Mohali signed an agreement with Novartis Healthcare Private Limited (NHPL).
The agreement was signed in the presence of Shri Manoj Joshi, Secretary, Department of Pharmaceuticals,
Ministry of Chemicals and Fertilizers in New Delhi today.
As part of this collaboration, a faculty member from NIPER Mohali has been selected as the recipient of
the Development Pioneer Grant for NIPERs, a prestigious initiative supported by NHPL. The grant
aims to promote cutting-edge research and encourage innovation-driven partnerships between academia
and industry.
Shri Manoj Joshi stated that this is a good initiative and that expanding such efforts will significantly
enhance the usefulness and impact of a researcher’s work in line with industry requirements. He stressed
on the need to move beyond pilot stages and ensure that research efforts are effectively aligned with
industry requirements, thereby strengthening the impact of industry-academia collaboration.
The Development Pioneer Grant provides a competitive platform for faculty members across all seven
NIPERs to submit their Research & Development proposals. The call for applications witnessed an
overwhelming response, with a total of 42 proposals submitted by distinguished faculty members.
Following a rigorous and structured evaluation by an independent jury, one faculty member from NIPER
Mohali was selected as the grant recipient. The Development Pioneer Grant for NIPERs is designed to
align with the vision of the Department of Pharmaceuticals to nurture strong industry-academia linkages.
It seeks to enhance academic research capabilities, support innovation, and drive pioneering advancements
in healthcare in India. This collaboration is expected to further integrate NIPER into the broader
pharmaceutical innovation ecosystem and reinforce the shared commitment to scientific excellence.Shri Awadhesh Kumar Choudhary, Senior Economic Advisor, Department of Pharmaceuticals; Dr. Kinny
Singh, Deputy Secretary, Department of Pharmaceuticals; Prof. Dulal Panda, Director, NIPER Mohali;
Prof. Joydev Kumar Laha, Professor, NIPER Mohali; Mr. Amitabh Dube, Country President India,
Novartis; and Ms. Sadhna Joglekar, Head Development India, Novartis were present during the signing
ceremony.
*****
PC/PM
(Release ID: 2252190) Visitor Counter : 567
Read this release in: Urdu , ही